BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33436578)

  • 1. Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis.
    Gao T; Ptashkin R; Bolton KL; Sirenko M; Fong C; Spitzer B; Menghrajani K; Ossa JEA; Zhou Y; Bernard E; Levine M; Martinez JSM; Zhang Y; Franch-Expósito S; Patel M; Braunstein LZ; Kelly D; Yabe M; Benayed R; Caltabellotta NM; Philip J; Paraiso E; Mantha S; Solit DB; Diaz LA; Berger MF; Klimek V; Levine RL; Zehir A; Devlin SM; Papaemmanuil E
    Nat Commun; 2021 Jan; 12(1):338. PubMed ID: 33436578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinction of lymphoid and myeloid clonal hematopoiesis.
    Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
    Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis: Origins and determinants of evolution.
    Mendez LM; Patnaik MM
    Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations.
    Jakubek YA; Reiner AP; Honigberg MC
    Transl Res; 2023 May; 255():171-180. PubMed ID: 36414227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal hematopoiesis and risk for hematologic malignancy.
    Warren JT; Link DC
    Blood; 2020 Oct; 136(14):1599-1605. PubMed ID: 32736382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of mosaic chromosomal alteration fitness.
    Pershad Y; Mack T; Poisner H; Jakubek YA; Stilp AM; Mitchell BD; Lewis JP; Boerwinkle E; Loos RJF; Chami N; Wang Z; Barnes K; Pankratz N; Fornage M; Redline S; Psaty BM; Bis JC; Shojaie A; Silverman EK; Cho MH; Yun JH; DeMeo D; Levy D; Johnson AD; Mathias RA; Taub MA; Arnett D; North KE; Raffield LM; Carson AP; Doyle MF; Rich SS; Rotter JI; Guo X; Cox NJ; Roden DM; Franceschini N; Desai P; Reiner AP; Auer PL; Scheet PA; Jaiswal S; Weinstock JS; Bick AG
    Nat Commun; 2024 May; 15(1):3800. PubMed ID: 38714703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal hematopoiesis and its emerging effects on cellular therapies.
    von Bonin M; Jambor HK; Teipel R; Stölzel F; Thiede C; Damm F; Kroschinsky F; Schetelig J; Chavakis T; Bornhäuser M
    Leukemia; 2021 Oct; 35(10):2752-2758. PubMed ID: 34215849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
    von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
    Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monogenic and polygenic inheritance become instruments for clonal selection.
    Loh PR; Genovese G; McCarroll SA
    Nature; 2020 Aug; 584(7819):136-141. PubMed ID: 32581363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk.
    Kishtagari A; Khan MAW; Li Y; Vlasschaert C; Marneni N; Silver AJ; von Beck K; Spaulding T; Stockton S; Snider C; Sochacki A; Dorand D; Mack TM; Ferrell PB; Xu Y; Bejan CA; Savona MR; Bick AG
    Blood Cancer J; 2024 Jan; 14(1):6. PubMed ID: 38225345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clonal hematopoiesis: a risk factor for leukemia and cardiovascular disease?].
    van Zeventer IA; Buisman SC; de Graaf AO; de Haan G; Jansen JH; Huls G
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33331716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors.
    Hong W; Li A; Liu Y; Xiao X; Christiani DC; Hung RJ; McKay J; Field J; Amos CI; Cheng C
    Cancer Res; 2022 Jan; 82(2):199-209. PubMed ID: 34815255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis: Molecular and clinical implications.
    Kusne Y; Xie Z; Patnaik MM
    Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of smoking and risk of clonal hematopoiesis.
    Levin MG; Nakao T; Zekavat SM; Koyama S; Bick AG; Niroula A; Ebert B; Damrauer SM; Natarajan P
    Sci Rep; 2022 May; 12(1):7248. PubMed ID: 35508625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
    Bolton KL; Ptashkin RN; Gao T; Braunstein L; Devlin SM; Kelly D; Patel M; Berthon A; Syed A; Yabe M; Coombs CC; Caltabellotta NM; Walsh M; Offit K; Stadler Z; Mandelker D; Schulman J; Patel A; Philip J; Bernard E; Gundem G; Ossa JEA; Levine M; Martinez JSM; Farnoud N; Glodzik D; Li S; Robson ME; Lee C; Pharoah PDP; Stopsack KH; Spitzer B; Mantha S; Fagin J; Boucai L; Gibson CJ; Ebert BL; Young AL; Druley T; Takahashi K; Gillis N; Ball M; Padron E; Hyman DM; Baselga J; Norton L; Gardos S; Klimek VM; Scher H; Bajorin D; Paraiso E; Benayed R; Arcila ME; Ladanyi M; Solit DB; Berger MF; Tallman M; Garcia-Closas M; Chatterjee N; Diaz LA; Levine RL; Morton LM; Zehir A; Papaemmanuil E
    Nat Genet; 2020 Nov; 52(11):1219-1226. PubMed ID: 33106634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes and consequences of clonal hematopoiesis.
    Weeks LD; Ebert BL
    Blood; 2023 Dec; 142(26):2235-2246. PubMed ID: 37931207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
    Goldman EA; Spellman PT; Agarwal A
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
    Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
    J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.
    Franch-Expósito S; Mehine M; Ptashkin RN; Bolton KL; Bandlamudi C; Srinivasan P; Zhang L; Goodell MA; Gedvilaite E; Menghrajani K; Sánchez-Vela P; Mandelker D; Comen E; Norton L; Benayed R; Gao T; Papaemmanuil E; Taylor B; Levine R; Offit K; Stadler Z; Berger MF; Zehir A
    JCO Precis Oncol; 2023 Aug; 7():e2300070. PubMed ID: 37561983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.